European Commission logo
polski polski
CORDIS - Wyniki badań wspieranych przez UE
CORDIS

VessConnect “Plug Flow” innovative technology providing patients a safer, more effective and less costly procedure for vascular anastomosis

Cel

Proposal title*
VessConnect “Plug & Flow” innovative technology providing every year to 270.000 European patients a safer, more effective and less costly procedure for vascular anastomosis

ACRONYM:

PLUGandFLOW

Free keywords
vascular anastomosis, microvascular anastomosis, microsurgery, NiTiNol, advanced materials, bio-absorbable Shape Memory Polymers, Advanced Material Innovation applied to surgical device, microsurgery

Abstract:
Vascular anastomosis, the surgical union of two blood vessels, has been technically performed in the same way for the last 100 years: suturing both ends of the vessels with microsutures. Even though several devices have appeared to ease the proceeding, none of them could improve traditional techniques. The result is a time-consuming procedure, with a long learning curve, which is not widely spread in private health systems because of its dangers and lack of efficiency and reliability.
Surg Solution’s, is a start-up company founded by two surgeons, one bio-medical engineer and a business consultant, that has designed, prototyped and solicited a PCT patent for a device, VessConnect, that will reduce costs and probabilities of failure in anastomosis procedures. The product, a stent-like device, relies on the shape-memory characteristics of NiTiNol.
Vascular anastomosis is a widely spread surgical procedure used in organ transplants and general reconstruction surgery, among others. Vessconnect has the potential to impact on the health improvement of the 270.000 European patients that we estimate need a surgery involving an anastomosis every year. Surg Solution aims to gain with VessConnect, 45% market-share of microvascular anastomosis in top European Markets in 5 years, generating €18M on revenues by 2021 with a 77% EBITDA margin.
VessConnect is at TRL6. We aim to launch the product by mid 2019, bringing to patients a safer surgery, to surgeons an easier procedure and to the healthcare system a more efficient solution to perform vascu

Zaproszenie do składania wniosków

H2020-SMEInst-2016-2017

Zobacz inne projekty w ramach tego zaproszenia

Szczegółowe działanie

H2020-SMEINST-1-2016-2017

Koordynator

SURG SOLUTIONS SL
Wkład UE netto
€ 50 000,00
Adres
AVENIDA MADRID 139 PLANTA 7 PUERTA 2
08028 BARCELONA
Hiszpania

Zobacz na mapie

MŚP

Organizacja określiła się jako MŚP (firma z sektora małych i średnich przedsiębiorstw) w czasie podpisania umowy o grant.

Tak
Region
Este Cataluña Barcelona
Rodzaj działalności
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Linki
Koszt całkowity
€ 71 429,00